EUVIMEDEUVIMED entdecken
Fallbericht

Incompatible red blood cell transfusion for hemolytic disease of the fetus and newborn secondary to anti‐U : A case report

Maha A Badawi iD, Heidi Al-Wassia

Transfusion · 2023

DOI: 10.1111/trf.17204 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transfusion, 2023. Verfasst von Maha A Badawi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Cesarean Section, Erythroblastosis, Fetal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hemolytic disease of the fetus and newborn (HDFN) is a challenging condition that may necessitate the need for intrauterine or neonatal transfusion. The ability to provide compatible blood depends on antibody identification and antigen prevalence. We describe the case of a newborn that was affected by HDFN secondary to a high‐prevalence antigen of unknown specificity. Study Design and Methods A 29‐year‐old mother underwent emergency cesarean section for fetal distress. The newborn had severe anemia and hyperbilirubinemia. Antibody screening and identification on maternal plasma revealed pan reactivity with negative autocontrol. The cord sample had the same pattern with positive Direct Antiglobulin Test. Incompatible group O red blood cells were transfused to the newborn with no complications.

Results

Testing the maternal sample at a reference laboratory revealed the presence of anti‐U at a high titer.

Discussion

In life‐threatening conditions, it may be necessary to transfuse incompatible units. In patients who require transfusion in the presence of an identified antibody against a high‐prevalence antigen, sources for rare blood should be explored. These include autologous donations for adults, collecting blood from relatives (including mothers), and fresh or frozen units from rare donors through rare donor registries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cesarean SectionErythroblastosis, FetalAdultInfant, NewbornHumansFemalePregnancyErythrocyte TransfusionErythrocytesFetusHemolysis

Stichwörter der Autor:innen

anti-Uhemolytic disease of the fetus and newbornhigh-prevalence antigen

Autor:innen und Institutionen

  • Department of Hematology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Blood Transfusion Services Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

ORCID-Profile: Maha A Badawi

Zitieren

APA

Badawi, M. A., & Al-Wassia, H. (2023). Incompatible red blood cell transfusion for hemolytic disease of the fetus and newborn secondary to anti‐U : A case report. Transfusion. https://doi.org/10.1111/trf.17204

Vancouver

Badawi MA, Al-Wassia H. Incompatible red blood cell transfusion for hemolytic disease of the fetus and newborn secondary to anti‐U : A case report. Transfusion. 2023. doi:10.1111/trf.17204

BibTeX
@article{Badawi2023,
  author = {Badawi, Maha A and Al-Wassia, Heidi},
  title = {Incompatible red blood cell transfusion for hemolytic disease of the fetus and newborn secondary to anti‐U : A case report},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17204}
}
Kostenlos starten →